Medpace Holdings Inc. (NASDAQ: MEDP) is 10.66% higher on its value in year-to-date trading and has touched a low of $58.72 and a high of $109.09 in the current 52-week trading range. The MEDP stock was last observed hovering at around $90.22 in the last trading session, with the day’s gains setting it 2.8% off its average median price target of $91.00 for the next 12 months. It is also -1.11% off the consensus price target high of $92.00 offered by 7 analysts, but current levels are -12.07% lower than the price target low of $83.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $93.02, the stock is 5.04% and 7.53% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.25 million and changing 3.10% at the moment leaves the stock 11.94% off its SMA200. MEDP registered 43.42% gain for a year compared to 6-month gain of 11.74%. The firm has a 50-day simple moving average (SMA 50) of $88.51 and a 200-day simple moving average (SMA200) of $85.60.
The stock witnessed a 3.79% loss in the last 1 month and extending the period to 3 months gives it a 26.76%, and is 2.83% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.84% over the week and 4.03% over the month.
Medpace Holdings Inc. (MEDP) has around 3600 employees, a market worth around $3.33B and $891.10M in sales. Current P/E ratio is 31.95 and Fwd P/E is 26.03. Profit margin for the company is 12.30%. Distance from 52-week low is 58.41% and -14.73% from its 52-week high. The company has generated returns on investments over the last 12 months (14.20%).
Medpace Holdings Inc. (MEDP) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Medpace Holdings Inc. (MEDP) is a “Overweight”. 7 analysts offering their recommendations for the stock have an average rating of 2.60, where 5 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Medpace Holdings Inc. is expected to release its quarterly report on 07/27/2020 and quarterly earnings per share for the current quarter are estimated at $0.4 with sales reaching $174.97M over the same period.The EPS is expected to grow by 35.20% this year, but quarterly earnings will post -5.30% year-over-year. Quarterly sales are estimated to shrink -18.30% in year-over-year returns.
Medpace Holdings Inc. (MEDP) Top Institutional Holders
370 institutions hold shares in Medpace Holdings Inc. (MEDP), with 8.46M shares held by insiders accounting for 23.91% while institutional investors hold 108.33% of the company’s shares. The shares outstanding are 36.02M, and float is at 26.91M with Short Float at 9.66%. Institutions hold 82.43% of the Float.
The top institutional shareholder in the company is Blackrock Inc. with over 4.54 million shares valued at $333.11 million. The investor’s holdings represent 12.83% of the MEDP Shares outstanding. As of Mar 30, 2020, the second largest holder is Vanguard Group, Inc. (The) with 3.72 million shares valued at $272.71 million to account for 10.51% of the shares outstanding. The other top investors are Wasatch Advisors Inc which holds 2.29 million shares representing 6.47% and valued at over $168.07 million, while Pendal Group Ltd holds 3.09% of the shares totaling 1.09 million with a market value of $80.3 million.
Medpace Holdings Inc. (MEDP) Insider Activity
A total of 12 insider transactions have happened at Medpace Holdings Inc. (MEDP) in the last six months, with sales accounting for 0 and purchases happening 12 times. The most recent transaction is an insider sale by GEIGER JESSE J, the company’s CFO & COO, Lab Operations. SEC filings show that GEIGER JESSE J sold 16,948 shares of the company’s common stock on Dec 20 at a price of $84.00 per share for a total of $1.42 million. Following the sale, the insider now owns 0.0 shares.
Medpace Holdings Inc. disclosed in a document filed with the SEC on Dec 19 that GEIGER JESSE J (CFO & COO, Lab Operations) sold a total of 14,400 shares of the company’s common stock. The trade occurred on Dec 19 and was made at $82.00 per share for $1.18 million. Following the transaction, the insider now directly holds 16948.0 shares of the MEDP stock.
Still, SEC filings show that on Oct 18, EWALD STEPHEN P (General Counsel & Corp. Secy.) disposed off 8,000 shares at an average price of $77.30 for $0.62 million. The insider now directly holds 0 shares of Medpace Holdings Inc. (MEDP).